PEOPLE - Graseby (UK) has announced the following appointments:
This article was originally published in Clinica
Executive Summary
Graseby (UK) has announced the following appointments, to take effect by April 1st, 1995: Dr T J Coombs, manager of Graseby Medical, becomes managing director of Graseby Product Monitoring; Dr A K Cousens, director and general manager of Graseby Intertest, becomes managing director of Graseby Medical; C D Johnson, president of Graseby Volkmann and Graseby Controls, is to be president-designate of Graseby Product Monitoring, North America, succeeding Alfred Frei, who retires later this year; Dr L Morell, vice-president and general manager of Graseby Infrared and Graseby Optronics, is named president of the US technology businesses, which includes Graseby Infrared, Graseby Optronics, Graseby Volkmann and Graseby Controls.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.